Abstract
Gompertzian analysis is a statistical technique which has been successfully applied to the analysis of amyotrophic lateral sclerosis (ALS) mortality in England and Wales, Japan and the United States. This paper analyses the consistent trend of rising ALS mortality in France over the years 1968–1990, a period during which crude mortality rose from 400 deaths in 1968 to 950 deaths in 1990. The findings indicate that age-specific mortality rates have risen at ages older than 54 years for men and 53 years for women and decreased slightly at younger ages. The evolving ALS mortality pattern is attributable to changing inter-disease competition resulting from the increased life expectancy of the French population, rather than to changing environmental aetiopathogenic factors or to substantial artefact effects.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bharucha NE, Schoenberg BS, Raven RH, Pickle LW, Byar DP, Mason TJ (1983) Geographic distribution of motor neuron disease and correlation with possible etiological factors. Neurology 33:911–915
Buckley J, Warlow C, Smith P, Hilton-Jones D, Irvine S, Tew JR (1983) Motor neuron disease in England and Wales, 1959–1979. J Neurol Neurosurg Psychiatry 46:197–205
Campbell AMG, Williams ER, Barltrop D (1970) Motor neuron disease and exposure to lead. J Neurol Neurosurg Psychiatry 33:877–885
Chancellor AM, Warlow CP, Carstairs V, Elton RA, Swingler RJ (1992) Affluence, age and motor neurone disease. J Epidemiol Community Health 46:172–173
Charcot JM (1874) De la sclerose laterale amyotrophique. Prog Med 2: 325–327, 342, 453–455
Chazot F, Vallat JM, Hugon J, Lubeau M, Dumas M (1986) ALS in Limousin (Limoges area, France). Neuroepidemiology 5:39–46
Durrleman S, Alperovitch A (1989) Increasing trend of ALS in France and elsewhere: are the changes real? Neurology 39:768–773
Flaten TP (1989) Rising mortality from Motoneuron Disease. Lancet 335:1018–1019
Gompertz B (1825) On the nature of the function expressive of the law of human mortality. Phil Trans R Soc Lond 115:513–585
Gunnarson L-G, Lindberg G (1989) Amyotrophic lateral sclerosis in Sweden 1970–83 and solvent exposure. Lancet 335:958
Hern JEC, Knight R, Davidson D, Forster A, Roberts R, Swingler RJ, Ashworth B, Chancellor AM, Cull RE, Fraser H, Jellinek EH, Holloway SM, McInnes A, Pentland B, Sandercock PAG, Warlow CP, Will R, Ballantyne JP, Behan PO, Bone I, Draper I, Durward F, Jamal G, Kennedy P, Metcalfe R, Thomas M, Weir AI, Fisher LR (1992) The scottish motor-neuron disease register: a prospective study of adult onset motor-neuron disease in Scotland. J Neurol Neurosurg Psychiatry 55:536–541
Hoffman PM, Brody JA (1971) The reliability of death certificate reporting for amyotrophic lateral scerlosis. J Chron Dis 24:5–8
INSERM (1980) Statistiques des causes de décés; résultats en France, I, 1976. Institut National de la Santé et de la Recherche Médicale, Paris
Juergens SM, Kurland LT, Okazaki H, Mulder DW (1980) ALS in Rochester, Minnesota 1925–77. Neurology 30:463–470
Kurtzke IF (1982) Epidemiology of amyotrophic lateral sclerosis. In: Rowland LP (ed) Human motor neuron diseases. Raven Press, New York, pp 281–302
Kurtzke JF (1991) Risk factors in amyotrophic lateral sclerosis. Adv Neurol 56:245–270
Kurtzke JF, Beebe GW (1980) Amyotrophic lateral sclerosis. 1. A case-controlled comparison based on ALS deaths. Neurology 30:453–462
Lestienne R (1988) On the thermodynamical and biological interpretation of the Gompertzian mortality rate distribution. Mech Ageing Dev 42:197–214
Li TM, Swash M, Alberman E (1985) Morbidity and mortality in motor neuron disease: comparison with multiple sclerosis and Parkinson's disease: age and sex specific rates and cohort analyses. J Neurol Neurosurg Psychiatry 48:320–327
Lilienfeld DE, Chan E, Ehland J, Godbold J, Landrigan PJ, Marsh G, Perl DP (1989) Rising mortality from motoneuron disease in the USA, 1962–1984. Lancet 335:710–712
Martyn CN (1990) Poliovirus and motor neuron disease. J Neurol 237:336–338
Mulder DW, Rosebaum RA, Layton DD (1972) Late progression of poliomyelitis or forme fruste amyotrophic lateral sclerosis? Mayo Clin Proc 47:756–771
Neilson S, Robinson I (1993) Cross sectional Gompertzian analysis: the development of a ‘Gompertz mortality ratio’ (GMR) and its applicability. Mech Ageing Dev 68:137–149
24.Neilson S, Robinson I (1993) Reinterpreting mortality statistics: some uses of Gompertzian analysis in epidemiological research. Clin Epidemiol 46:1063–1069
Neilson S, Robinson i, Hunter M (1992) Longitudinal Gompertzian analysis of ALS mortality in England and Wales, 1963–1990: estimates of susceptibility in the general population. Mech Ageing Dev 64:201–216
Neilson S, Robinson I, Hunter M (1993) Static and dynamic models of interdisease competition: past and projected mortality from amyotrophic lateral sclerosis and multiple sclerosis. Mech Ageing Dev 66:223–241
Neilson S, Robinson i, Clifford Rose F, Hunter M (1993) Rising mortality from motor neurone disease — an explanation. Acta Neurol Scand 87:184–191
Neilson S, Robinson I, Kondo K (1993) A new analysis of mortality from motor neurone disease in Japan, 1950–1990: rise and fall in the postwar years. J Neurol Sci 117:46–53
Norris FH (1992) Motor-neuron disease. BMJ 304:459–460
Olivares L, San Esteban E, Alter M (1972) Mexican “resistance” to amyotrophic lateral sclerosis. Arch Neurol 27:397–402
Olshansky SJ (1993) The aging of the human species. Sci Am 268(4):46–52
O'Malley F, Dean G, Elian M (1987) Multiple sclerosis and motor neurone disease: survival and how certified after death. J Epidemiol Community Health 41:14–17
Riggs JE (1990) Longitudinal Gompertzian analysis of adult mortality in the United States, 1900–1986. Mech Ageing Dev 54:235–247
Riggs JE (1990) Longitudinal Gompertzian analysis of amyotrophic lateral sclerosis mortality in the United States, 1977–1986 — evidence for an inherently susceptible subset. Mech Ageing Dev 55:207–220
Riggs JE (1990) Longitudinal Gompertzian analysis of Parkinson's disease mortality in the United States, 1955–1986 — the dramatic increase in overall mortality since 1980 is the natural consequence of deterministic mortality dynamics. Mech Ageing Dev 55: 221–233
Riggs JE (1991) The decline of martality due to stroke: a competitive and deterministic perspective. Neurology 41: 1335–1338
Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng H-X, Rahmani Z, Krizus A, McKenna-Yasek D, Cayabyab A, Gaston SM, Berger R, Tanzi RE, Halperin JJ, Herzfeldt B, Van den Bergh R, Hung W-Y, Bird T, Deng G, Mulder DW, Smith C, Laing NG, Soriano E, Pericak-Vance MA, Haines J, Rouleau GA, Gusella JS, Horvitz HR, Brown R (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59–62
Siddique T, Figlewicz DA, Pericak-Vance MA, Haines JL, Rouleau G, Jeffers AJ, Sapp P, Hung W-Y, Bebout J, McKenna-Yasek D, Deng G, Horvitz HR, Gusella JF, Brown RH, Roses AD (1991) Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity. N Engl J Med 324:1381–1384
Strehler BL, Mildvan AS (1960) General theory of mortality and ageing. Science 132:14–21
Swash M, Schwartz MS, Li T-M (1989) Trends in mortality from motoneuron disease. Lancet 335:958
WHO (1957) The International Classification of Disease, seventh revision. The World Health Organisation, Geneva
WHO (1968) The International Classification of Disease, eighth revision. The World Health Organisation, Geneva
WHO (1985) The International Classification of Disease, ninth revision. The World Health Organisation, Geneva
Williams DB, Windebank AJ (1991) Motor neuron disease (amyotrophic lateral sclerosis). Mayo Clinic Proc 66:54–82
Yoshida S, Mulder DW, Kurland LT, Chu C-P, Okazaki H (1986) Follow-up study on amyotrophic lateral sclerosis in Rochester, Minn., 1925 through 1984. Neuroepidemiology 5:61–70
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Neilson, S., Robinson, I. & Alperovitch, A. Rising amyotrophic lateral sclerosis mortality in France 1968–1990: Increased life expectancy and inter-disease competition as an explanation. J Neurol 241, 448–455 (1994). https://doi.org/10.1007/BF00900964
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00900964